Insights

Press Coverage | 09.09.24

FTC Backs Teva Orange Book Delisting At Fed. Circ.

Press Coverage | 03.28.23

Practitioners Mostly Agree Amgen Won’t Be A Sea Change, But Some Predict Grim Consequences

Press Coverage | 03.24.23

Amgen Supreme Court Arguments Aren't Just About Biology

Press Coverage | 12.29.22

What’s In Store For IP In 2023?

Press Coverage | 07.01.21

Everything You Need To Know About SCOTUS’ Minerva Ruling On Assignor Estoppel

Press Coverage | 01.30.19

Shareholder Mark Remus is Quoted in Westlaw Journal Intellectual Property

Press Coverage | 01.24.19

Shareholder Mark Remus is Quoted in IPPRo Magazine

Press Coverage | 01.23.19

Shareholder Mark Remus is Quoted in Intellectual Property Magazine

Press Coverage | 01.22.19

Shareholder Mark Remus is Quoted in Law360

Press Coverage | 12.21.18

Westlaw Journal Intellectual Property Quotes Brinks Shareholder Mark Remus

Press Coverage | 12.05.18

IPPro Magazine Quotes Brinks Shareholder Mark Remus

Press Coverage | 12.03.18

Law360 Quotes Brinks Shareholder Mark Remus

Press Coverage | 03.14.17

Mark Remus Mentioned in Chicago Daily Law Bulletin

Press Coverage | 01.12.17

2017 Shareholders' Announcement Published by Various Media Outlets

Press Coverage | 01.06.17

CDLB Publishes New Shareholders Announcement

Press Coverage | 08.04.16

Mark Remus Drafts Article for Life Sciences Intellectual Property Review

Press Coverage | 09.30.15

Mark Remus mentioned in CDLB